102146 dsm-102146 dsm102146 dsm 102146 Bacteroides sp.
Sanger 21, Sanger_21
faeces from healthy human
United Kingdom of Great Britain and Northern Ireland
Date of sampling:
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
<- H. Browne, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; Sanger_21
<- H. Browne, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; Sanger_21. Faeces from healthy human; United Kingdom, Cambridgeshire. Taxonomy/description (25531). (Medium 110, 37°C, anaerobic).
For detailed information:
1 (provisional classification by DSMZ)
|actively growing culture||140,- €|
|Price Category for this culture: 1|
Freight and handling charges will be added. See price list.